In RADIANCE trial, 178 heart failure patients with ejection fraction of < 35% and NewYork Heart Association (NYHA) class II–III symptoms on a stable regimen of digoxin, diuretics, and an ACE-inhibitor (captopril or enalapril) were randomized to withdrawal or continuation of digoxin for 12 weeks. This evidence concerns the gene ACE and heart failure.